Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol.
about
Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study.A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas.Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy.Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention.The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not?Mannitol for the prevention of cisplatin-induced nephrotoxicity: A retrospective comparison of hydration plus mannitol versus hydration alone in inpatient and outpatient regimens at a large academic medical center.Clinical Outcomes of Wulingsan Subtraction Decoction Treatment of Postoperative Brain Edema and Fever as a Complication of Glioma Neurosurgery.A retrospective evaluation of furosemide and mannitol for prevention of cisplatin-induced nephrotoxicity.Nebivolol Ameliorates Cisplatin-Induced Nephrotoxicity in Rats.Renal toxicity and chemotherapy in children with cancer.Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin.Should mannitol be reinstated in prevention of cisplatin-induced nephrotoxicity?
P2860
Q35837903-16232FAC-D5CF-43CE-ADD3-A1BF5A36BB27Q36355684-AD4CCE3E-83A5-4EF3-95AE-E5F92D05829CQ36638185-856707E3-C8C1-4611-9AE3-964B94CBA789Q38601857-F2ECDBEA-3D5E-4CA9-B18C-4CFF0E5B2B26Q38626960-04E6E78C-F14A-4CB0-805D-0C2669CBFB67Q38641130-64D36CF5-F256-4034-9CC8-3247DAF64BB3Q38879709-DFCD2C57-2891-480D-9CEF-0C88ED03150AQ38888490-6B762335-2DD2-4E08-9C44-B033CA074426Q38919157-E816E69C-CB7A-4401-B93A-1D24582CA26FQ46969982-843D656C-69B9-4E47-B23A-C2A47D3BE381Q48321401-EFE2727C-FC4B-4575-A326-B400C897C9DCQ50103946-A7840DFE-5F04-40D9-8BCB-3D1641E6A89EQ53838971-8F834721-AE6F-4844-8B33-415D5B621517
P2860
Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol.
@en
Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol.
@nl
type
label
Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol.
@en
Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol.
@nl
prefLabel
Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol.
@en
Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol.
@nl
P2093
P2860
P356
P1476
Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol.
@en
P2093
Anna C Snavely
Christine M Walko
Jared Weiss
Juneko Grilley-Olson
Katherine P Morgan
Larry W Buie
Lucas S Wind
P2860
P304
P356
10.1177/1060028014533303
P407
P577
2014-04-28T00:00:00Z